United Kingdom (UK) Meningococcal Vaccines Market (2025-2031) Outlook | Value, Revenue, Share, Companies, Trends, Size, Analysis, Industry, Forecast & Growth

Market Forecast By Product (Polysaccharide, Conjugate), By Age Group (Infants, Children, Adolescents & Young Adults, Adults), By Distribution Channel (Pharmacies, Community Clinics, Public Health Agencies, Others) And Competitive Landscape
Product Code: ETC332649 Publication Date: Aug 2022 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United Kingdom (UK) Meningococcal Vaccines Market Overview

The meningococcal vaccines market covers vaccines used to protect against meningococcal disease, a serious bacterial infection. This market includes the development, production, and distribution of vaccines to prevent outbreaks and protect public health.

Drivers of the market

In the UK, the meningococcal vaccines market growth is driven by public health initiatives, vaccination programs, and advancements in vaccine technologies. Demand is influenced by outbreaks, epidemiological surveillance, and healthcare policies aimed at preventing meningococcal disease among children and young adults.

Challenges of the market

Similarly, challenges in the Meningococcal Vaccines market include addressing vaccine efficacy against evolving meningococcal strains and optimizing immunization strategies for diverse population groups. Regulatory compliance with vaccine safety standards and global vaccination campaigns demand extensive clinical trials and regulatory approvals. Market players must navigate through healthcare policy reforms and vaccine supply chain logistics while addressing public health concerns and vaccine hesitancy, influencing market access and adoption rates.

Government Policy of the market

Government policies in the UK focus on public health immunization programs and vaccine safety in the meningococcal vaccines market. Regulatory frameworks oversee vaccine production standards and immunization schedules to prevent disease outbreaks and protect public health.

Key Highlights of the Report:

  • United Kingdom (UK) Meningococcal Vaccines Market Outlook
  • Market Size of United Kingdom (UK) Meningococcal Vaccines Market, 2024
  • Forecast of United Kingdom (UK) Meningococcal Vaccines Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Revenues & Volume for the Period 2021-2031
  • United Kingdom (UK) Meningococcal Vaccines Market Trend Evolution
  • United Kingdom (UK) Meningococcal Vaccines Market Drivers and Challenges
  • United Kingdom (UK) Meningococcal Vaccines Price Trends
  • United Kingdom (UK) Meningococcal Vaccines Porter's Five Forces
  • United Kingdom (UK) Meningococcal Vaccines Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Product for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Polysaccharide for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Conjugate for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Age Group for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Infants for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Children for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Adolescents & Young Adults for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Adults for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Distribution Channel for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Pharmacies for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Community Clinics for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Public Health Agencies for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume By Others for the Period 2021-2031
  • United Kingdom (UK) Meningococcal Vaccines Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Age Group
  • Market Opportunity Assessment By Distribution Channel
  • United Kingdom (UK) Meningococcal Vaccines Top Companies Market Share
  • United Kingdom (UK) Meningococcal Vaccines Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Meningococcal Vaccines Company Profiles
  • United Kingdom (UK) Meningococcal Vaccines Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Meningococcal Vaccines Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Meningococcal Vaccines Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Meningococcal Vaccines Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Meningococcal Vaccines Market - Industry Life Cycle

3.4 United Kingdom (UK) Meningococcal Vaccines Market - Porter's Five Forces

3.5 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.7 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United Kingdom (UK) Meningococcal Vaccines Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in preventing meningococcal disease

4.2.2 Government initiatives and vaccination programs to increase immunization rates

4.2.3 Rising incidence of meningococcal disease in the UK

4.3 Market Restraints

4.3.1 High cost of meningococcal vaccines leading to affordability issues for some individuals or families

4.3.2 Vaccine hesitancy and misinformation affecting vaccination rates

4.3.3 Regulatory challenges and approval processes for new meningococcal vaccines

5 United Kingdom (UK) Meningococcal Vaccines Market Trends

6 United Kingdom (UK) Meningococcal Vaccines Market, By Types

6.1 United Kingdom (UK) Meningococcal Vaccines Market, By Product

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Product, 2021-2031F

6.1.3 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021-2031F

6.1.4 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Conjugate, 2021-2031F

6.2 United Kingdom (UK) Meningococcal Vaccines Market, By Age Group

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Infants, 2021-2031F

6.2.3 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Children, 2021-2031F

6.2.4 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Adolescents & Young Adults, 2021-2031F

6.2.5 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Adults, 2021-2031F

6.3 United Kingdom (UK) Meningococcal Vaccines Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Pharmacies, 2021-2031F

6.3.3 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Community Clinics, 2021-2031F

6.3.4 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Public Health Agencies, 2021-2031F

6.3.5 United Kingdom (UK) Meningococcal Vaccines Market Revenues & Volume, By Others, 2021-2031F

7 United Kingdom (UK) Meningococcal Vaccines Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Meningococcal Vaccines Market Export to Major Countries

7.2 United Kingdom (UK) Meningococcal Vaccines Market Imports from Major Countries

8 United Kingdom (UK) Meningococcal Vaccines Market Key Performance Indicators

8.1 Number of individuals vaccinated against meningococcal disease

8.2 Percentage of infants and children receiving recommended meningococcal vaccinations

8.3 Rate of meningococcal disease cases in the UK

8.4 Funding allocated towards meningococcal vaccination programs

8.5 Public perception and sentiment towards meningococcal vaccines

9 United Kingdom (UK) Meningococcal Vaccines Market - Opportunity Assessment

9.1 United Kingdom (UK) Meningococcal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United Kingdom (UK) Meningococcal Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.3 United Kingdom (UK) Meningococcal Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United Kingdom (UK) Meningococcal Vaccines Market - Competitive Landscape

10.1 United Kingdom (UK) Meningococcal Vaccines Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Meningococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All